Qvanteq AG is a venture leader China
Arik Zucker is one of the winners of the venture leader China program.
Qvanteq AG chosen as a 2015 Red Herring Europe Winner
Amsterdam, Netherlands – Red Herring announced its Red Herring Europe award winners today, recognizing Europe’s leading private companies and celebrating these startups’ innovations and technologies across their respective industries. Red Herring’s Top 100 Europe list has become a mark of distinction for identifying promising new companies and entrepreneurs. Red Herring’s editors were among the first […]
First patient enrolled in the QUEST I clinical study
Qvanteq AG today announced that it has enrolled the first patient in the First in Man (FiM) clinical study QUEST I, this is following earlier regulatory approval from the Dutch and Swiss authorities. The aim of the QUEST I study is to assess feasibility and safety of the Qstent, a bioactive, coating-free coronary stent. The […]
Qvanteq AG is a Top 100 Swiss Startup
Qvanteq was amongst the “Top 100 Swiss Startups” for the 4th time in a row.